Liver cancer often remains undetected until advanced stages. Learn about the causes and how you can protect yourself with expert prevention tips.

Genetic engineering made it possible to clone or replicate ‘foreign’ DNA in a host or a living ... The first rDNA-based Hepatitis B vaccine, developed in 1988, was based on a specific protein ...

HBx binds the promoter region of the DLEU2 lncRNA ... HBx and DLEU2 modulates transcription from the HBV covalently closed circular DNA minichromosome, hence boosting HBV replication, and from host ...

Chronic hepatitis B virus (HBV) infection continues to pose a major global health threat. The virus evades immune responses and antiviral therapies due to the persistence of covalently closed circular ...

Hepatitis B virus (HBV) is the leading cause of cirrhosis, hepatocellular carcinoma, and liver-related death globally.1,2 The highest prevalence is found in low-income and middle-income countries ...

Precision BioSciences (DTIL) announced that the U.S. Food and Drug Administration or FDA has cleared the Investigational New Drug application ...

PBGENE-HBV, the first LNP gene editing technology studied for Hepatitis B, was safe and well tolerated PBGENE-HBV demonstrated substantial antiviral activity measured by reduction of Hepatitis B ...

Hepatitis B can lead to liver disease. But we can prevent and manage this viral infection. Here’s what we know about the ...

Atomic force microscopy images show hepatitis B DNA in its natural state (left) and a zoomed-in look at how it wraps around human histones during an infection (right). The research team determined ...